Electrical Muscle Stimulation Effect Compared With Myofascial Release on Quality of Life in Female Fibromyalgia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Electric Stimulation
- Sponsor
- Cairo University
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Assessment of change of body mass index
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
the study was done to investigate the effect of Electrical Muscle Stimulation as muscle strengthening versus the effect of myofascial releasing on quality of life in female fibromyalgia patients while following Mediterranean diet.
Detailed Description
Fibromyalgia is a chronic pain condition characterized by unrefreshing sleep, physical exhaustion, and cognitive difficulties. It affects all populations worldwide and requires a diagnosis of widespread pain for at least three months. People with Fibromyalgia show abnormal endogenous pain modulation, including reduced conditioned pain modulation and exercise-induced hypoalgesia. Exercise is considered a first-line treatment for Fibromyalgia. Electrical myostimulation has been shown to improve pain, sleep subscales, and quality of life. A potential causal link between Fibromyalgia and micronutrient deficiency has been suggested. The study focuses on fibromyalgia, which affects mostly females and is difficult to diagnose easily. Electrical myostimulation and myofascial release are effective treatments for Fibromyalgia.
Investigators
Maha Mostafa Osman
principal investigator
Cairo University
Eligibility Criteria
Inclusion Criteria
- •Sixty females have diagnosed suffering from fibromyalgia syndrome.
- •Their ages will be ranged from 45 to 55 years old.
- •Their body mass index will be ranged from 25 to 34 ( overweight and obese type 1)
- •They have willingness to participate in this study.
Exclusion Criteria
- •Peripheral vascular diseases.
- •Drug abuse.
- •Chest disease. ( either obstructive or restrictive ).
- •Clinical signs of sever cardiac events ( eg. Congestive heart disease).
Outcomes
Primary Outcomes
Assessment of change of body mass index
Time Frame: at baseline and after 6 weeks
to measure body weight and height to calculate BMI for characterizing the sample.
Assessment of change of pressure pain threshold using algometry
Time Frame: at baseline and after 6 weeks
Algometry is a useful tool for assessing central allodynia and hyperalgesia in FM and other pain conditions. It can provide insights into psychological factors influencing pain experience, new dynamic pain indicators, and neuroimaging techniques.
Secondary Outcomes
- assessment of fibromyalgia using Fibromyalgia Impact Questionnaire(at baseline and after 6 weeks)